| Miss Rachel Ann Aaron, MD | |
|
15790 Paul Vega Md Dr, Hammond, LA 70403-1436 | |
| (985) 230-1683 | |
| (985) 230-2072 |
| Full Name | Miss Rachel Ann Aaron |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 20 Years |
| Location | 15790 Paul Vega Md Dr, Hammond, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265636658 | NPI | - | NPPES |
| 1066842 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 200723 (Louisiana) | Primary |
| 207R00000X | Internal Medicine | M.D.200723 (Louisiana) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Oaks Medical Center, L L C | Hammond, LA | Hospital |
| Ochsner Medical Center - Baton Rouge | Baton rouge, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Oaks Medical Center, Llc | 2466629522 | 228 |
News Archive
Access Pharmaceuticals, Inc., a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has received initial prescriptions for its lead product, MuGard – an FDA-approved, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of radiotherapy and/or chemotherapy.
Inter Press Service reports that the September 2010 U.N. Generally Assembly meeting will feature a three-day special session (UNGASS) on the Millennium Development Goals (MDGs).
Pfizer Inc. today announced that it has entered into an agreement with AstraZeneca for the over-the-counter (OTC) rights for NEXIUM (esomeprazole magnesium), a leading prescription drug currently approved to treat the symptoms of gastroesophageal reflux disease (GERD).
Alzheimer's disease is the sixth leading cause of death in the United States and the only cause of death among the top 10 in America without a way to prevent, cure or even slow its progression, according to the Alzheimer's Association. Today, 5.4 million Americans are living with the disease, and another American develops it every 69 seconds.
Novasep, a leading supplier of manufacturing solutions to the life science industries, today announces the launch of BioSC Lab, the next-generation low pressure chromatography equipment for the biopharmaceutical industry.
› Verified 2 days ago
| Entity Name | Our Lady Of Lake Ascension, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306899067 PECOS PAC ID: 3577452259 Enrollment ID: O20040311000822 |
News Archive
Access Pharmaceuticals, Inc., a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has received initial prescriptions for its lead product, MuGard – an FDA-approved, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of radiotherapy and/or chemotherapy.
Inter Press Service reports that the September 2010 U.N. Generally Assembly meeting will feature a three-day special session (UNGASS) on the Millennium Development Goals (MDGs).
Pfizer Inc. today announced that it has entered into an agreement with AstraZeneca for the over-the-counter (OTC) rights for NEXIUM (esomeprazole magnesium), a leading prescription drug currently approved to treat the symptoms of gastroesophageal reflux disease (GERD).
Alzheimer's disease is the sixth leading cause of death in the United States and the only cause of death among the top 10 in America without a way to prevent, cure or even slow its progression, according to the Alzheimer's Association. Today, 5.4 million Americans are living with the disease, and another American develops it every 69 seconds.
Novasep, a leading supplier of manufacturing solutions to the life science industries, today announces the launch of BioSC Lab, the next-generation low pressure chromatography equipment for the biopharmaceutical industry.
› Verified 2 days ago
| Entity Name | North Oaks Medical Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962709501 PECOS PAC ID: 2466629522 Enrollment ID: O20120125000648 |
News Archive
Access Pharmaceuticals, Inc., a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has received initial prescriptions for its lead product, MuGard – an FDA-approved, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of radiotherapy and/or chemotherapy.
Inter Press Service reports that the September 2010 U.N. Generally Assembly meeting will feature a three-day special session (UNGASS) on the Millennium Development Goals (MDGs).
Pfizer Inc. today announced that it has entered into an agreement with AstraZeneca for the over-the-counter (OTC) rights for NEXIUM (esomeprazole magnesium), a leading prescription drug currently approved to treat the symptoms of gastroesophageal reflux disease (GERD).
Alzheimer's disease is the sixth leading cause of death in the United States and the only cause of death among the top 10 in America without a way to prevent, cure or even slow its progression, according to the Alzheimer's Association. Today, 5.4 million Americans are living with the disease, and another American develops it every 69 seconds.
Novasep, a leading supplier of manufacturing solutions to the life science industries, today announces the launch of BioSC Lab, the next-generation low pressure chromatography equipment for the biopharmaceutical industry.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Rachel Ann Aaron, MD 15790 Paul Vega Md Dr, Hammond, LA 70403-1436 Ph: (985) 230-1683 | Miss Rachel Ann Aaron, MD 15790 Paul Vega Md Dr, Hammond, LA 70403-1436 Ph: (985) 230-1683 |
News Archive
Access Pharmaceuticals, Inc., a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has received initial prescriptions for its lead product, MuGard – an FDA-approved, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of radiotherapy and/or chemotherapy.
Inter Press Service reports that the September 2010 U.N. Generally Assembly meeting will feature a three-day special session (UNGASS) on the Millennium Development Goals (MDGs).
Pfizer Inc. today announced that it has entered into an agreement with AstraZeneca for the over-the-counter (OTC) rights for NEXIUM (esomeprazole magnesium), a leading prescription drug currently approved to treat the symptoms of gastroesophageal reflux disease (GERD).
Alzheimer's disease is the sixth leading cause of death in the United States and the only cause of death among the top 10 in America without a way to prevent, cure or even slow its progression, according to the Alzheimer's Association. Today, 5.4 million Americans are living with the disease, and another American develops it every 69 seconds.
Novasep, a leading supplier of manufacturing solutions to the life science industries, today announces the launch of BioSC Lab, the next-generation low pressure chromatography equipment for the biopharmaceutical industry.
› Verified 2 days ago
Robert C. Peltier, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 15790 Paul Vega Md Dr, Hammond, LA 70403 Phone: 985-230-3668 Fax: 985-230-2072 | |
Michael Lindley, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 15790 Paul Vega Md Dr, Hospital Medicine, Hammond, LA 70403 Phone: 985-230-3066 Fax: 985-230-2072 |